AbbVie Inc (ABBV)
158.17
-9.12
(-5.45%)
USD |
NYSE |
Apr 26, 13:31
AbbVie Total Assets (Quarterly): 134.71B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 134.71B |
| September 30, 2023 | 136.22B |
| June 30, 2023 | 135.37B |
| March 31, 2023 | 134.54B |
| December 31, 2022 | 138.80B |
| September 30, 2022 | 141.32B |
| June 30, 2022 | 143.19B |
| March 31, 2022 | 143.21B |
| December 31, 2021 | 146.53B |
| September 30, 2021 | 148.86B |
| June 30, 2021 | 147.97B |
| March 31, 2021 | 150.50B |
| December 31, 2020 | 150.56B |
| September 30, 2020 | 149.62B |
| June 30, 2020 | 149.53B |
| March 31, 2020 | 91.20B |
| December 31, 2019 | 89.12B |
| September 30, 2019 | 59.44B |
| June 30, 2019 | 57.14B |
| March 31, 2019 | 56.77B |
| December 31, 2018 | 59.35B |
| September 30, 2018 | 66.16B |
| June 30, 2018 | 61.64B |
| March 31, 2018 | 69.34B |
| December 31, 2017 | 70.79B |
| Date | Value |
|---|---|
| September 30, 2017 | 68.84B |
| June 30, 2017 | 66.99B |
| March 31, 2017 | 65.66B |
| December 31, 2016 | 66.10B |
| September 30, 2016 | 66.63B |
| June 30, 2016 | 67.21B |
| March 31, 2016 | 53.72B |
| December 31, 2015 | 53.05B |
| September 30, 2015 | 54.83B |
| June 30, 2015 | 53.86B |
| March 31, 2015 | 26.70B |
| December 31, 2014 | 27.51B |
| September 30, 2014 | 28.45B |
| June 30, 2014 | 29.04B |
| March 31, 2014 | 28.66B |
| December 31, 2013 | 29.20B |
| September 30, 2013 | 28.25B |
| June 30, 2013 | 27.91B |
| March 31, 2013 | 27.17B |
| December 31, 2012 | 27.01B |
| September 30, 2012 | 22.73B |
| June 30, 2012 | 17.71B |
| March 31, 2012 | 18.96B |
| December 31, 2011 | 19.52B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
57.14B
Minimum
Jun 2019
150.56B
Maximum
Dec 2020
128.83B
Average
141.32B
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
| Amgen Inc | 97.15B |
| Immunogen Inc (DELISTED) | 822.10M |
| Johnson & Johnson | 167.56B |
| Eli Lilly and Co | 64.01B |
| Merck & Co Inc | 106.68B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 124.31B |
| Shareholders Equity (Quarterly) | 10.36B |
| Debt to Equity Ratio | 5.732 |
| Current Ratio | 0.8721 |
| Net Debt Paydown Yield | 0.75% |